Medical stocks were on the move Tuesday as companies offered guidance and research updates at the JPMorgan Healthcare Conference in San Francisco. Biotech The Medicines Co. (MDCO) warmed up for its afternoon presentation by announcing late-stage trial results for its cardiovascular drug cangrelor. As usual, the company is saving the details for a future medical conference, but it did say the thrombosis-preventing drug compared favorably to the